SANFILIPPO JOHN B & SON INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SANFILIPPO JOHN B & SON INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 26, 2025 | $1.11B | Aug 20, 2025 |
| FY2025 | Jun 27, 2024 | $1.07B | Aug 20, 2025 |
| FY2025 | Jun 29, 2023 | $999.69M | Aug 20, 2025 |
| FY2024 | Jun 30, 2022 | $955.87M | Aug 21, 2024 |
| FY2023 | Jun 24, 2021 | $858.48M | Aug 23, 2023 |
| FY2022 | Jun 25, 2020 | $880.09M | Aug 24, 2022 |
| FY2021 | Jun 27, 2019 | $876.20M | Aug 18, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Jun 24, 2021 | $206.74M | Aug 18, 2021 |
| FY2021 | Mar 25, 2021 | $207.89M | Aug 18, 2021 |
| FY2021 | Dec 25, 2020 | $233.58M | Aug 18, 2021 |
| FY2021 | Sep 25, 2020 | $210.27M | Aug 18, 2021 |
| FY2021 | Jun 25, 2020 | $204.20M | Aug 18, 2021 |
| FY2021 | Mar 26, 2020 | $211.62M | Aug 18, 2021 |
| FY2021 | Dec 26, 2019 | $246.42M | Aug 18, 2021 |
| FY2021 | Sep 26, 2019 | $217.85M | Aug 18, 2021 |
| FY2020 | Jun 27, 2019 | $216.76M | Aug 19, 2020 |
| FY2020 | Mar 28, 2019 | $201.83M | Aug 19, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 26, 2025 | $203.47M | Aug 20, 2025 |
| FY2025 | Jun 27, 2024 | $214.14M | Aug 20, 2025 |
| FY2025 | Jun 29, 2023 | $211.63M | Aug 20, 2025 |
| FY2024 | Jun 30, 2022 | $199.63M | Aug 21, 2024 |
| FY2021 | Jun 24, 2021 | $46.81M | Aug 18, 2021 |
| FY2021 | Mar 25, 2021 | $46.05M | Aug 18, 2021 |
| FY2021 | Dec 25, 2020 | $52.80M | Aug 18, 2021 |
| FY2021 | Sep 25, 2020 | $39.33M | Aug 18, 2021 |
| FY2021 | Jun 25, 2020 | $40.74M | Aug 18, 2021 |
| FY2021 | Mar 26, 2020 | $42.81M | Aug 18, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 26, 2025 | $58.93M | Aug 20, 2025 |
| FY2025 | Jun 27, 2024 | $60.25M | Aug 20, 2025 |
| FY2025 | Jun 29, 2023 | $62.86M | Aug 20, 2025 |
| FY2024 | Jun 30, 2022 | $61.79M | Aug 21, 2024 |
| FY2021 | Jun 24, 2021 | $12.34M | Aug 18, 2021 |
| FY2021 | Mar 25, 2021 | $14.70M | Aug 18, 2021 |
| FY2021 | Dec 25, 2020 | $19.89M | Aug 18, 2021 |
| FY2021 | Sep 25, 2020 | $12.81M | Aug 18, 2021 |
| FY2021 | Jun 25, 2020 | $10.26M | Aug 18, 2021 |
| FY2021 | Mar 26, 2020 | $13.47M | Aug 18, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 26, 2025 | $84.71M | Aug 20, 2025 |
| FY2025 | Jun 27, 2024 | $85.19M | Aug 20, 2025 |
| FY2025 | Jun 29, 2023 | $90.22M | Aug 20, 2025 |
| FY2024 | Jun 30, 2022 | $87.44M | Aug 21, 2024 |
| FY2021 | Jun 24, 2021 | $17.41M | Aug 18, 2021 |
| FY2021 | Mar 25, 2021 | $21.10M | Aug 18, 2021 |
| FY2021 | Dec 25, 2020 | $27.80M | Aug 18, 2021 |
| FY2021 | Sep 25, 2020 | $18.87M | Aug 18, 2021 |
| FY2021 | Jun 25, 2020 | $15.62M | Aug 18, 2021 |
| FY2021 | Mar 26, 2020 | $19.40M | Aug 18, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 26, 2025 | $3.49M | Aug 20, 2025 |
| FY2025 | Jun 27, 2024 | $3.62M | Aug 20, 2025 |
| FY2025 | Jun 29, 2023 | $3.36M | Aug 20, 2025 |
| FY2024 | Jun 30, 2022 | $2.83M | Aug 21, 2024 |
| FY2023 | Jun 24, 2021 | $2.00M | Aug 23, 2023 |
| FY2022 | Jun 25, 2020 | $999.0K | Aug 24, 2022 |
| FY2021 | Jun 27, 2019 | $892.0K | Aug 18, 2021 |
| FY2020 | Jun 28, 2018 | $701.0K | Aug 19, 2020 |
| FY2019 | Jun 29, 2017 | $658.0K | Aug 21, 2019 |
| FY2018 | Jun 30, 2016 | $653.0K | Aug 22, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 26, 2025 | $30.55M | Aug 20, 2025 |
| FY2025 | Jun 27, 2024 | $101.67M | Aug 20, 2025 |
| FY2025 | Jun 29, 2023 | $124.66M | Aug 20, 2025 |
| FY2024 | Jun 30, 2022 | $19.60M | Aug 21, 2024 |
| FY2023 | Jun 24, 2021 | $104.70M | Aug 23, 2023 |
| FY2022 | Jun 25, 2020 | $63.61M | Aug 24, 2022 |
| FY2021 | Jun 27, 2019 | $83.46M | Aug 18, 2021 |
| FY2020 | Jun 28, 2018 | $66.15M | Aug 19, 2020 |
| FY2019 | Jun 29, 2017 | $52.67M | Aug 21, 2019 |
| FY2018 | Jun 30, 2016 | $89.25M | Aug 22, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 26, 2025 | $50.71M | Aug 20, 2025 |
| FY2025 | Jun 27, 2024 | $28.31M | Aug 20, 2025 |
| FY2025 | Jun 29, 2023 | $20.73M | Aug 20, 2025 |
| FY2024 | Jun 30, 2022 | $17.75M | Aug 21, 2024 |
| FY2023 | Jun 24, 2021 | $25.18M | Aug 23, 2023 |
| FY2022 | Jun 25, 2020 | $15.02M | Aug 24, 2022 |
| FY2021 | Jun 27, 2019 | $15.08M | Aug 18, 2021 |
| FY2020 | Jun 28, 2018 | $13.23M | Aug 19, 2020 |
| FY2019 | Jun 29, 2017 | $10.89M | Aug 21, 2019 |
| FY2018 | Jun 30, 2016 | $15.02M | Aug 22, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 26, 2025 | $597.60M | Aug 20, 2025 |
| FY2025 | Jun 27, 2024 | $515.58M | Aug 20, 2025 |
| FY2024 | Jun 29, 2023 | $425.29M | Aug 21, 2024 |
| FY2023 | Jun 30, 2022 | $447.26M | Aug 23, 2023 |
| FY2022 | Jun 24, 2021 | $398.46M | Aug 24, 2022 |
| FY2021 | Jun 25, 2020 | $407.46M | Aug 18, 2021 |
| FY2020 | Jun 27, 2019 | $391.30M | Aug 19, 2020 |
| FY2019 | Jun 28, 2018 | $415.85M | Aug 21, 2019 |
| FY2018 | Jun 29, 2017 | $398.06M | Aug 22, 2018 |
| FY2017 | Jun 30, 2016 | $391.16M | Aug 23, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 26, 2025 | $236.91M | Aug 20, 2025 |
| FY2025 | Jun 27, 2024 | $192.96M | Aug 20, 2025 |
| FY2024 | Jun 29, 2023 | $133.08M | Aug 21, 2024 |
| FY2023 | Jun 30, 2022 | $168.44M | Aug 23, 2023 |
| FY2022 | Jun 24, 2021 | $155.96M | Aug 24, 2022 |
| FY2021 | Jun 25, 2020 | $169.22M | Aug 18, 2021 |
| FY2020 | Jun 27, 2019 | $136.75M | Aug 19, 2020 |
| FY2019 | Jun 28, 2018 | $172.85M | Aug 21, 2019 |
| FY2018 | Jun 29, 2017 | $162.59M | Aug 22, 2018 |
| FY2017 | Jun 30, 2016 | $139.97M | Aug 23, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 26, 2025 | $360.70M | Aug 20, 2025 |
| FY2025 | Jun 27, 2024 | $322.61M | Aug 20, 2025 |
| FY2025 | Jun 29, 2023 | $292.21M | Aug 20, 2025 |
| FY2025 | Jun 30, 2022 | $278.82M | Aug 20, 2025 |
| FY2024 | Jun 24, 2021 | $242.49M | Aug 21, 2024 |
| FY2023 | Jun 25, 2020 | $238.24M | Aug 23, 2023 |
| FY2022 | Jun 27, 2019 | $254.56M | Aug 24, 2022 |
| FY2021 | Jun 28, 2018 | $243.00M | Aug 18, 2021 |
| FY2020 | Jun 29, 2017 | $235.47M | Aug 19, 2020 |
| FY2019 | Jun 30, 2016 | $251.19M | Aug 21, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 26, 2025 | $11.75M | Aug 20, 2025 |
| FY2025 | Jun 27, 2024 | $11.75M | Aug 20, 2025 |
| FY2025 | Jun 29, 2023 | $11.75M | Aug 20, 2025 |
| FY2024 | Jun 30, 2022 | $9.65M | Aug 21, 2024 |
| FY2023 | Jun 25, 2021 | $9.65M | Aug 23, 2023 |
| FY2022 | Jun 24, 2021 | $9.65M | Aug 24, 2022 |
| FY2022 | Jun 26, 2020 | $9.65M | Aug 24, 2022 |
| FY2021 | Jun 25, 2020 | $9.65M | Aug 18, 2021 |
| FY2021 | Jun 28, 2019 | $9.65M | Aug 18, 2021 |
| FY2020 | Jun 27, 2019 | $9.65M | Aug 19, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 26, 2025 | $221.50M | Aug 20, 2025 |
| FY2025 | Jun 27, 2024 | $186.97M | Aug 20, 2025 |
| FY2024 | Jun 29, 2023 | $161.51M | Aug 21, 2024 |
| FY2023 | Jun 30, 2022 | $153.59M | Aug 23, 2023 |
| FY2022 | Jun 24, 2021 | $126.34M | Aug 24, 2022 |
| FY2021 | Jun 25, 2020 | $124.06M | Aug 18, 2021 |
| FY2020 | Jun 27, 2019 | $137.71M | Aug 19, 2020 |
| FY2019 | Jun 28, 2018 | $127.32M | Aug 21, 2019 |
| FY2018 | Jun 29, 2017 | $123.19M | Aug 22, 2018 |
| FY2017 | Jun 30, 2016 | $143.57M | Aug 23, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 26, 2025 | $585.0K | Aug 20, 2025 |
| FY2025 | Jun 27, 2024 | $484.0K | Aug 20, 2025 |
| FY2024 | Jun 29, 2023 | $1.95M | Aug 21, 2024 |
| FY2023 | Jun 30, 2022 | $415.0K | Aug 23, 2023 |
| FY2022 | Jun 24, 2021 | $672.0K | Aug 24, 2022 |
| FY2021 | Jun 25, 2020 | $1.54M | Aug 18, 2021 |
| FY2020 | Jun 27, 2019 | $1.59M | Aug 19, 2020 |
| FY2019 | Jun 28, 2018 | $1.45M | Aug 21, 2019 |
| FY2018 | Jun 29, 2017 | $1.96M | Aug 22, 2018 |
| FY2017 | Jun 30, 2016 | $2.22M | Aug 23, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Jun 27, 2013 | $42.36M | Aug 28, 2013 |
| FY2012 | Jun 28, 2012 | $48.93M | Aug 30, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 26, 2025 | 5 | Aug 20, 2025 |
| FY2025 | Jun 27, 2024 | 5 | Aug 20, 2025 |
| FY2025 | Jun 29, 2023 | 5 | Aug 20, 2025 |
| FY2024 | Jun 30, 2022 | 5 | Aug 21, 2024 |
| FY2021 | Jun 24, 2021 | 1 | Aug 18, 2021 |
| FY2021 | Mar 25, 2021 | 1 | Aug 18, 2021 |
| FY2021 | Dec 25, 2020 | 1 | Aug 18, 2021 |
| FY2021 | Sep 25, 2020 | 1 | Aug 18, 2021 |
| FY2021 | Jun 25, 2020 | 0 | Aug 18, 2021 |
| FY2021 | Mar 26, 2020 | 1 | Aug 18, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 26, 2025 | 5 | Aug 20, 2025 |
| FY2025 | Jun 27, 2024 | 5 | Aug 20, 2025 |
| FY2025 | Jun 29, 2023 | 5 | Aug 20, 2025 |
| FY2024 | Jun 30, 2022 | 5 | Aug 21, 2024 |
| FY2021 | Jun 24, 2021 | 1 | Aug 18, 2021 |
| FY2021 | Mar 25, 2021 | 1 | Aug 18, 2021 |
| FY2021 | Dec 25, 2020 | 1 | Aug 18, 2021 |
| FY2021 | Sep 25, 2020 | 1 | Aug 18, 2021 |
| FY2021 | Jun 25, 2020 | 0 | Aug 18, 2021 |
| FY2021 | Mar 26, 2020 | 1 | Aug 18, 2021 |